Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Type II Diabetes Mellitus with Hepatocellular Carcinoma Occurrence - a Case Control Study from Kathmandu Valley

  • Jha, Dipendra Kumar (Nepalese Army Institute of Health Sciences) ;
  • Mittal, Ankush (Nepalese Army Institute of Health Sciences) ;
  • Gupta, Satrudhan Pd. (Nepalese Army Institute of Health Sciences) ;
  • Pandeya, Dipendra Raj (Nepalese Army Institute of Health Sciences) ;
  • Sathian, Brijesh (Department of Community Medicine, Manipal College of Medical Sciences)
  • Published : 2012.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To assess associations of Type II DM with hepatocellular carcinoma occurrence in Nepal. Materials and Methods: This case control study was carried out using data retrieved from the register maintained in the Department of Biochemistry of Nepalese Army Institute of Health Sciences between 1st January, 2012, and 31st August, 2012. The variables collected were age, gender, HbA1c. All biochemical parameters were analyzed in the Central Laboratory of our hospital by standard validated methods. One way ANOVA was used to examine the statistical significant difference between groups with the LSD post-hoc test for comparison of means of case groups. Odds ratios (OR) were calculated using simple logistic-regression analysis. Results: Etiological factors for HCC were HBV, HCV, alcohol and cryptogenic cirrhosis. The highest age group belonged to the etiological category of HCV with a mean of $71.9{\pm}3.6$ (CI 69.3, 74.5) years and the lowest age group to the etiological category of HBV with $61.7{\pm}5.3$(CI 57.9, 65.5) years. The main imperative basis of HCC in present study was HCV (39.5%) and second most significant cause of HCC was alcohol (26%). Glycated hemoglobin was found to be more in males with HCC (7.9%) as compared to females (7.3%). The percentage of Type II diabetes mellitus was greater in HCC patients when compared to controls. This difference was statistically significant with an odd ratio of 4.63 (p<0.001). Conclusion: Type II DM influences incidence, risk of recurrence, overall survival, and treatment-related complications in HCC patients.

Keywords

References

  1. Chiou WK, Huang BY, Chou WY, et al (2011). Incidences of cancers in diabetic and non-diabetic hospitalized adult patients in Taiwan. Asian Pac J Cancer Prev, 12, 1577-81.
  2. Dogan E, Yalcin S, Koca D, et al (2012). Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev, 13, 2985-90. https://doi.org/10.7314/APJCP.2012.13.6.2985
  3. Donadon V, Balbi M, Casarin P, et al (2008). Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin. World J Gastroenterol, 14, 5695-700. https://doi.org/10.3748/wjg.14.5695
  4. Eckerbom S, Bergqvist Y, Jeppsson JO (1994). Improved method for analysis of glycated haemoglobin by ion exchange chromatography. Ann Clin Biochem, 31, 355-60. https://doi.org/10.1177/000456329403100409
  5. Gao J, Xie L, Yang WS, et al (2012). Risk factors of hepatocellular carcinoma--current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
  6. Kablan A, Saunders RA, Szkudlarek-Mikho M, et al (2010). Prieurianin causes weight loss in diet-induced obese mice and inhibits adipogenesis in cultured preadipocytes. J Diabetes Metab, 1, 101.
  7. Kryger P, Mathiesen LR, Møller AM, et al (1981). Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen. J Clin Microbiol, 13, 405-9.
  8. Ma HB, Huang T, Han F, et al (2012). Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysis. Asian Pac J Cancer Prev, 13, 2841-6. https://doi.org/10.7314/APJCP.2012.13.6.2841
  9. Mori M, Saitoh S, Takagi S, et al (2000). A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer. Asian Pac J Cancer Prev, 1, 269-76.
  10. Morss AS, Edelman ER (2007). Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem, 282, 14635-44. https://doi.org/10.1074/jbc.M608565200
  11. Richardson LC, Pollack LA (2005). Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol, 2, 48-53. https://doi.org/10.1038/ncponc0062
  12. Xu GJ, Cai S, Wu JB (2012). Effect of insulin-like growth factor-1 on bone morphogenetic protein-2 expression in hepatic carcinoma SMMC7721 cells through the p38 MAPK signaling pathway. Asian Pac J Cancer Prev, 13, 1183-6. https://doi.org/10.7314/APJCP.2012.13.4.1183
  13. Ye JZ, Miao Z, Wu F, et al (2012). Recurrence after Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma: A Meta-analysis. Asian Pac J Cancer Prev, 13, 1771-7. https://doi.org/10.7314/APJCP.2012.13.5.1771
  14. Yu H, Pardoll D, Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer, 9, 798-809. https://doi.org/10.1038/nrc2734

Cited by

  1. Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review vol.60, pp.9, 2015, https://doi.org/10.1007/s10620-015-3760-3
  2. Malignant Neoplasm Burden in Nepal - Data from the Seven Major Cancer Service Hospitals for 2012 vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8659